1389 related articles for article (PubMed ID: 24510883)
1. In vitro models of the blood-brain barrier.
Czupalla CJ; Liebner S; Devraj K
Methods Mol Biol; 2014; 1135():415-37. PubMed ID: 24510883
[TBL] [Abstract][Full Text] [Related]
2. Baicalin reduces the permeability of the blood-brain barrier during hypoxia in vitro by increasing the expression of tight junction proteins in brain microvascular endothelial cells.
Zhu H; Wang Z; Xing Y; Gao Y; Ma T; Lou L; Lou J; Gao Y; Wang S; Wang Y
J Ethnopharmacol; 2012 Jun; 141(2):714-20. PubMed ID: 21920425
[TBL] [Abstract][Full Text] [Related]
3. A neurovascular blood-brain barrier in vitro model.
Zehendner CM; White R; Hedrich J; Luhmann HJ
Methods Mol Biol; 2014; 1135():403-13. PubMed ID: 24510882
[TBL] [Abstract][Full Text] [Related]
4. An improved in vitro blood-brain barrier model: rat brain endothelial cells co-cultured with astrocytes.
Abbott NJ; Dolman DE; Drndarski S; Fredriksson SM
Methods Mol Biol; 2012; 814():415-30. PubMed ID: 22144323
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies.
Eigenmann DE; Xue G; Kim KS; Moses AV; Hamburger M; Oufir M
Fluids Barriers CNS; 2013 Nov; 10(1):33. PubMed ID: 24262108
[TBL] [Abstract][Full Text] [Related]
6. A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters.
Perrière N; Yousif S; Cazaubon S; Chaverot N; Bourasset F; Cisternino S; Declèves X; Hori S; Terasaki T; Deli M; Scherrmann JM; Temsamani J; Roux F; Couraud PO
Brain Res; 2007 May; 1150():1-13. PubMed ID: 17434463
[TBL] [Abstract][Full Text] [Related]
7. Development of a three-dimensional, all-human in vitro model of the blood-brain barrier using mono-, co-, and tri-cultivation Transwell models.
Hatherell K; Couraud PO; Romero IA; Weksler B; Pilkington GJ
J Neurosci Methods; 2011 Aug; 199(2):223-9. PubMed ID: 21609734
[TBL] [Abstract][Full Text] [Related]
8. Real-time acquisition of transendothelial electrical resistance in an all-human,
Maherally Z; Fillmore HL; Tan SL; Tan SF; Jassam SA; Quack FI; Hatherell KE; Pilkington GJ
FASEB J; 2018 Jan; 32(1):168-182. PubMed ID: 28883042
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB).
Booth R; Kim H
Lab Chip; 2012 Apr; 12(10):1784-92. PubMed ID: 22422217
[TBL] [Abstract][Full Text] [Related]
10. Influence of basolateral condition on the regulation of brain microvascular endothelial tight junction properties and barrier function.
Colgan OC; Collins NT; Ferguson G; Murphy RP; Birney YA; Cahill PA; Cummins PM
Brain Res; 2008 Feb; 1193():84-92. PubMed ID: 18177846
[TBL] [Abstract][Full Text] [Related]
11. Transfection of brain capillary endothelial cells in primary culture with defined blood-brain barrier properties.
Burkhart A; Thomsen LB; Thomsen MS; Lichota J; Fazakas C; Krizbai I; Moos T
Fluids Barriers CNS; 2015 Aug; 12():19. PubMed ID: 26246240
[TBL] [Abstract][Full Text] [Related]
12. Side by side comparison between dynamic versus static models of blood-brain barrier in vitro: a permeability study.
Santaguida S; Janigro D; Hossain M; Oby E; Rapp E; Cucullo L
Brain Res; 2006 Sep; 1109(1):1-13. PubMed ID: 16857178
[TBL] [Abstract][Full Text] [Related]
13. Hyperglycaemia promotes cerebral barrier dysfunction through activation of protein kinase C-β.
Shao B; Bayraktutan U
Diabetes Obes Metab; 2013 Nov; 15(11):993-9. PubMed ID: 23617822
[TBL] [Abstract][Full Text] [Related]
14. Membrane configuration optimization for a murine in vitro blood-brain barrier model.
Wuest DM; Wing AM; Lee KH
J Neurosci Methods; 2013 Jan; 212(2):211-21. PubMed ID: 23131353
[TBL] [Abstract][Full Text] [Related]
15. Effects of pericytes and various cytokines on integrity of endothelial monolayer originated from blood-nerve barrier: an in vitro study.
Iwasaki T; Kanda T; Mizusawa H
J Med Dent Sci; 1999 Mar; 46(1):31-40. PubMed ID: 12160211
[TBL] [Abstract][Full Text] [Related]
16. In vitro porcine blood-brain barrier model for permeability studies: pCEL-X software pKa(FLUX) method for aqueous boundary layer correction and detailed data analysis.
Yusof SR; Avdeef A; Abbott NJ
Eur J Pharm Sci; 2014 Dec; 65():98-111. PubMed ID: 25239510
[TBL] [Abstract][Full Text] [Related]
17. Co-culture based blood-brain barrier in vitro model, a tissue engineering approach using immortalized cell lines for drug transport study.
Zhang Z; McGoron AJ; Crumpler ET; Li CZ
Appl Biochem Biotechnol; 2011 Jan; 163(2):278-95. PubMed ID: 20652765
[TBL] [Abstract][Full Text] [Related]
18. Closing the gap between the in-vivo and in-vitro blood-brain barrier tightness.
Cohen-Kashi Malina K; Cooper I; Teichberg VI
Brain Res; 2009 Aug; 1284():12-21. PubMed ID: 19501061
[TBL] [Abstract][Full Text] [Related]
19. Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli.
Silwedel C; Förster C
J Neuroimmunol; 2006 Oct; 179(1-2):37-45. PubMed ID: 16884785
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of bEnd5 cell line as an in vitro model for the blood-brain barrier under normal and hypoxic/aglycemic conditions.
Yang T; Roder KE; Abbruscato TJ
J Pharm Sci; 2007 Dec; 96(12):3196-213. PubMed ID: 17828743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
